Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study

Authors: Down S, Alzaid A, Polonsky WH, Belton A, Edelman S, Gamerman V, Nagel F, Lee J, Emmerson J, Capehorn M.

Abstract

Aims: Physician-patient communication when discussing the need for additional oral medication for type 2 diabetes (add-on) may affect the self-care of people with this condition. We aimed to investigate physicians’ recalled experiences of the add-on consultation.

Methods: We conducted a cross-sectional survey of physicians treating people with type 2 diabetes in 26 countries, as part of a large cross-national study of physician-patient communication during early treatment of type 2 diabetes (IntroDia®). The survey battery included novel questions about physician experiences at add-on and the Jefferson Scale of Physician Empathy.

Results: Of 9247 eligible physicians, 6753 responded (73.0% response rate). Most (82%) agreed that physician-patient discussions at add-on strongly influence patients’ disease acceptance and treatment adherence. Half the physicians reported ≥1 challenge in most or all add-on conversations, with a significant inverse relationship between frequency of challenges and Jefferson Scale of Physician Empathy score (standardised β coefficient: -0.313; p < 0.001). Physicians estimated that only around half their patients with type 2 diabetes follow their self-care advice. Exploratory factor analysis of physician beliefs about why their patients did not follow recommendations yielded two distinct dimensions: psychosocial barriers (e.g. depressed mood) and personal failings of the patient (e.g. not enough willpower) (r = 0.37, p < 0.001).

Conclusions: Physicians’ empathy and beliefs about their patients may play a significant role in their success with the add-on conversation and, consequently, promotion of patient engagement and self-care. Although the study was limited by its retrospective, cross-sectional nature, the findings from IntroDia® may inform efforts to improve diabetes care.

Source: https://pubmed.ncbi.nlm.nih.gov/30641173/

Share the Post:

BDI Monthly Events

September 10Case Consultation
September 10: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at [email protected] if you are in the greater San Diego area and would like further information about this program.
September 14T1D Meet-up
September 14: Time for another T1D meet-up! GrownupT1Ds, a wonderful nonprofit here in southern California, which organizes fun social events for adults with type 1 diabetes here in southern California. This next one will be at 2 pm at Altar Society Brewing & Coffee Co, 230 Pine Ave, Long Beach. This event is free, but space is limited. Please RSVP at www.grownupt1ds.org
September 27Scripps Presentation
September 27: Dr. Polonsky (BDI President), will be presenting The Power of Psych at Scripps Whittier Diabetes Institute’s 2025 Updates in Diabetes Management, in La Jolla (CA). See: https://www.scripps.org/events/2025-updates-in-diabetes-management-september-27-2025